Changes in the etiology of valvular heart disease in the rapidly aging Korean population

Shin Yi Jang1, Eun-Young Ju2, Su Ra Seo3

  • 1Division of Cardiology, Department of Medicine, Center for Cardiovascular and Stroke Imaing, Vascular Center, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Republic of Korea.

Insights

The prevalence of non-rheumatic valvular heart disease significantly increased in Korea from 2006 to 2011, particularly in older adults. This trend highlights the need for updated cardiovascular healthcare strategies.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Valvular heart disease (VHD) poses a significant health burden.
  • Understanding trends in VHD causes is crucial for public health planning.

Purpose of the Study:

  • To analyze changes in the prevalence of valvular heart disease in Korea between 2006 and 2011.
  • To identify demographic shifts in VHD causes.

Main Methods:

  • Utilized Korean National Health Insurance Service data from 2006-2011.
  • Included primary diagnoses of non-rheumatic and rheumatic mitral and aortic valve disorders.
  • Calculated age-standardized cumulative prevalence rates.

Main Results:

  • Non-rheumatic VHD prevalence rose from 70.6 to 110.3 per 100,000 persons.
  • Prevalence increased in both women (42.2 to 65.2) and men (28.4 to 45.1).
  • The most significant increase was observed in individuals aged 65 and older.

Conclusions:

  • Non-rheumatic VHD prevalence increased notably between 2006 and 2011, especially in the elderly population.
  • Rheumatic VHD prevalence remained relatively stable.
  • Healthcare services require adaptation for an aging population with increasing VHD rates.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
367
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
354
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K